Amgen buys Micromet for anti-leukemia drug
Thursday, January 26, 2012 - 14:01
in Mathematics & Economics
Biotech giant Amgen said Thursday it was buying the German-American cancer research firm Micromet, giving it access to Micromet's promising leukemia therapy.